drugset / Trial / NCT04464850
Intravenous Versus Oral Iron Therapy in Hemodialysis Patients
RandomizedParallel-groupSingle-blindTreatment
Summary
This study is aim to compare the efficacy of intravenous versus oral iron therapy regarding the hemoglobin levels, iron status and erythropoietin dosage in maintenance hemodialysis patients
Timeline
- Start
- 2020-07-29
- Primary completion
- 2021-01-31
- Completion
- 2022-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Iron Sulfate | Small molecule | 200 mg | Oral |
| Subject | Iron sucrose | Unknown | 100 mg | Intravenous |
| Subject | Iron sucrose | Unknown | 200 mg | Intravenous |